Cheap Biotech Stocks for 2019
Now that Congress is split, with Republicans in charge of the Senate and Democrats holding down the House, there is no way that Washington can get rid of Obamacare. At least not right now.
On top of that, it's unlikely that President Donald Trump's highly touted plan to cut drug prices will pass both houses. That means it's a great time to reconsider some cheap biotech stocks for 2019-especially after the abysmal year the biotech industry has seen.
With that in mind, the biotech stock forecast for 2019 looks bullish, especially for the best undervalued biotech stocks.
Biotech stocks have not exactly had a stellar.
Den vollständigen Artikel lesen ...
Now that Congress is split, with Republicans in charge of the Senate and Democrats holding down the House, there is no way that Washington can get rid of Obamacare. At least not right now.
On top of that, it's unlikely that President Donald Trump's highly touted plan to cut drug prices will pass both houses. That means it's a great time to reconsider some cheap biotech stocks for 2019-especially after the abysmal year the biotech industry has seen.
With that in mind, the biotech stock forecast for 2019 looks bullish, especially for the best undervalued biotech stocks.
Biotech stocks have not exactly had a stellar.
Den vollständigen Artikel lesen ...